longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

510660

510660
2.3380.43%( -0.010 )

LongbridgeAI

Fosun expects 1H profit attributable to owners at RMB 1.5 billion-RMB 1.8 billion

PUBT
Jul 29, 2026 at 09:33 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Fosun International forecasts H1 2026 profit attributable to owners of RMB 1.5-1.8 billion, a 127%-172% increase year-over-year. The outlook is driven by stronger industrial operating profits and improved quality across core businesses. Key subsidiaries also reported positive results: Fosun Pharma saw Q1 revenue and net profit growth; Pramerica Fosun Life Insurance exceeded full-year 2025 profit in H1; and Yuyuan and Hainan Mining provided profitable guidance for the first half.

  • Fosun forecast 1H 2026 profit attributable to owners of RMB 1.5-1.8 billion, up about 127%-172% from a year earlier. * Outlook driven by stronger industrial operating profit, improved operating quality, resilience across core businesses. * Fosun Pharma posted Q1 revenue of RMB 10.07 billion, up 6.93%; attributable net profit RMB 871 million, up 13.87%. * Pramerica Fosun Life Insurance delivered 1H net profit of RMB 786 million, above its full-year 2025 result. * Yuyuan guided to 1H net profit of RMB 120-170 million; Hainan Mining guided to RMB 470-550 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fosun International Limited published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607290532PR_NEWS_USPR_____HK14692) on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Login to unlock696characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

FOSUN PHARMA

FOSUN PHARMA

HK02196

+1.04%

FOSUN INTL

FOSUN INTL

HK00656

-0.10%

FOSUN PHARMA

FOSUN PHARMA

SH600196

+0.51%